--- title: "Rockwell Medical (RMTI) news: reverse split" url: "https://aibio.space/companies/rockwell-medical/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "RMTI reverse split news: Rockwell Medical sets 1-for-10 reverse stock split for July 1, 2026. Rockwell Medical, Inc. (NASDAQ: RMTI), United States." --- RMTI Rockwell Medical, Inc. NASDAQ · United States # Rockwell Medical (RMTI) news RMTI reverse split news Listings · 2026-07-20 ## [Rockwell Medical regains Nasdaq bid price compliance, matter closed](https://aibio.space/news/rockwell-medical-regains-nasdaq-bid-price-compliance-matter-closed/) Nasdaq told Rockwell Medical on July 16, 2026 that the company had regained compliance with the $1.00 minimum bid price, and closed the matter. The 8-K does not give the closing prices behind that finding. ## Latest Rockwell Medical news 1. 2026-06-29 Listings [Rockwell Medical sets 1-for-10 reverse stock split for July 1, 2026](https://aibio.space/news/rockwell-medical-sets-1-10-reverse-stock-split-july-1-2026/) Rockwell Medical's one-for-ten reverse split takes effect at 12:01 a.m. Eastern Time on July 1, 2026. The certificate was filed June 24, and the company says fractional shares will be paid in cash at the June 30 closing price, adjusted by the company. 2. 2026-06-15 Listings [Rockwell Medical holders approve reverse stock split amendment](https://aibio.space/news/rockwell-medical-holders-approve-reverse-stock-split-amendment/) Holders cast 16,993,038 votes for the reverse split and 6,597,036 against it at the June 12, 2026 annual meeting. The 8-K reports the result but gives no split ratio and no effective date. 3. 2026-04-30 Listings [Rockwell Medical to put reverse stock split to a vote at June 12, 2026 meeting](https://aibio.space/news/rockwell-medical-put-reverse-stock-split-vote-june-12-2026-meeting/) DEK:Rockwell Medical's proxy asks holders to approve a reverse split at a virtual meeting on June 12, 2026. Approval needs a majority of the votes cast, and the company's 2025 net loss was $5.3 million. 4. 2024-11-13 Financings [Rockwell Medical files to sell up to $25,000,000 of stock at market](https://aibio.space/news/rockwell-medical-files-sell-up-25-000-000-stock-market/) Rockwell Medical may sell up to $25,000,000 of stock through Cantor Fitzgerald, which takes a commission of up to 3.0%. At the assumed $4.43 price, the filing says new buyers would face an immediate dilution of $3.33 a share. ## Rockwell Medical at a glance - **Ticker**: RMTI - **Listing**: NASDAQ - **Country**: United States - **Cash, Jun 30, 2026**: $10.5 million ### Related companies - [Polaryx Therapeutics](https://aibio.space/companies/polaryx-therapeutics/) NASDAQ: PLYX - [Apollomics](https://aibio.space/companies/apollomics/) NASDAQ: APLM - [CervoMed](https://aibio.space/companies/cervomed/) NASDAQ: CRVO - [RenovoRx](https://aibio.space/companies/renovorx/) NASDAQ: RNXT - [Lantheus Holdings](https://aibio.space/companies/lantheus/) NASDAQ: LNTH - [Citius Pharmaceuticals](https://aibio.space/companies/citius-pharmaceuticals/) NASDAQ: CTXR - [Dermata Therapeutics](https://aibio.space/companies/dermata-therapeutics/) NASDAQ: DRMA - [Nutriband](https://aibio.space/companies/nutriband/) NASDAQ: NTRB ### Also on NASDAQ - [Septerna](https://aibio.space/companies/septerna/) SEPN - [Journey Medical](https://aibio.space/companies/journey-medical/) DERM - [Caris Life Sciences](https://aibio.space/companies/caris-life-sciences/) CAI - [Allogene Therapeutics](https://aibio.space/companies/allogene-therapeutics/) ALLO - [AC Immune SA](https://aibio.space/companies/ac-immune/) ACIU - [CytoMed Therapeutics](https://aibio.space/companies/cytomed-therapeutics/) GDTC ## What Rockwell Medical does Rockwell Medical, Inc. is a healthcare company that develops, manufactures, commercializes and distributes a portfolio of hemodialysis products for dialysis providers worldwide. It is a supplier of liquid and dry, acid and bicarbonate concentrates for dialysis patients in the United States. Hemodialysis is the most common form of end-stage kidney disease treatment and is usually performed in freestanding outpatient dialysis centers, hospital-based outpatient centers, skilled nursing facilities, or a patient's home. Rockwell manufactures its hemodialysis concentrates under current Good Manufacturing Practices. The text names CitraPure, Dri-Sate, RenalPure and SteriLyte as its registered trademarks. The Business section also states that the company files its annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K with the SEC, and makes them available free of charge on its website. | Product or program | What it is | Stage | |---|---|---| | Hemodialysis concentrates | Liquid and dry, acid and bicarbonate concentrates for dialysis patients in the United States | commercially distributed | Summarised from the company's [10-K filed Mar 26, 2026](https://www.sec.gov/Archives/edgar/data/1041024/000162828026021186/rmti-20251231.htm). ## Rockwell Medical annual financials | Line | FY2025 | FY2024 | |---|---|---| | Research and development | [$0](https://www.sec.gov/Archives/edgar/data/1041024/000162828026021186/) | [$19,000](https://www.sec.gov/Archives/edgar/data/1041024/000162828026021186/) | | Net income (loss) | [-$5.3 million](https://www.sec.gov/Archives/edgar/data/1041024/000162828026021186/) | [-$480,000](https://www.sec.gov/Archives/edgar/data/1041024/000162828026021186/) | | Cash from operations | [-$659,000](https://www.sec.gov/Archives/edgar/data/1041024/000162828026021186/) | [$4.2 million](https://www.sec.gov/Archives/edgar/data/1041024/000162828026021186/) | | Cash and equivalents | [$10.7 million](https://www.sec.gov/Archives/edgar/data/1041024/000162828026056461/) | [$15.7 million](https://www.sec.gov/Archives/edgar/data/1041024/000162828026021186/) | | Short-term investments | [$14.3 million](https://www.sec.gov/Archives/edgar/data/1041024/000162828026021186/) | [$5.9 million](https://www.sec.gov/Archives/edgar/data/1041024/000162828026021186/) | Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $10.5 million. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about Rockwell Medical Did Rockwell Medical do a reverse stock split? Our latest story on this, dated Jun 29, 2026: "Rockwell Medical sets 1-for-10 reverse stock split for July 1, 2026". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/rockwell-medical-sets-1-10-reverse-stock-split-july-1-2026/). What is the ticker symbol of Rockwell Medical? Rockwell Medical, Inc. trades under the ticker RMTI on NASDAQ. Where is Rockwell Medical listed? Rockwell Medical, Inc. is listed on NASDAQ. What is the SEC CIK of Rockwell Medical? The SEC Central Index Key (CIK) for Rockwell Medical, Inc. is 1041024. Its filings are on SEC EDGAR. How many shares does Rockwell Medical have outstanding? 4,030,465 shares as of 2026-08-10, per the cover page of its 10-Q filed 2026-08-13. Which country or territory is Rockwell Medical listed under? Our directory records Rockwell Medical, Inc. under United States. What does Rockwell Medical do? Our directory classifies Rockwell Medical, Inc. as: Biopharma / pharmaceuticals. This is a directory classification, not a description of the pipeline. What is the ISIN of Rockwell Medical? The ISIN recorded for Rockwell Medical, Inc. is US7743744093. Does aibio.space cover Rockwell Medical? aibio.space lists Rockwell Medical, Inc. among 2,820 public biotech companies and publishes its news here as stories appear. Where is Rockwell Medical incorporated? SEC records list its state or country of incorporation as DE. What does Rockwell Medical develop? Rockwell Medical, Inc. is a healthcare company that develops, manufactures, commercializes and distributes a portfolio of hemodialysis products for dialysis providers worldwide. It is a supplier of liquid and dry, acid and bicarbonate concentrates for dialysis patients in the United States. What is Hemodialysis concentrates from Rockwell Medical? Hemodialysis concentrates: Liquid and dry, acid and bicarbonate concentrates for dialysis patients in the United States Stage: commercially distributed. Is Rockwell Medical profitable? Rockwell Medical, Inc. reported a net loss of $5.3 million for the fiscal year ended Dec 31, 2025, and used $659,000 of cash in operations, per its annual report to the SEC. How much does Rockwell Medical spend on research and development? $0 in the fiscal year ended Dec 31, 2025, per its annual report. How much cash does Rockwell Medical have? $10.5 million in cash at Jun 30, 2026, per its 10-Q. ## Investor discussion: Rockwell Medical Members talk about Rockwell Medical (RMTI). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Rockwell Medical, newest first. Each line links the filing it comes from. 1. 2026-07-20 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 8.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1041024/000162828026048752/rmti-20260720.htm) 2. 2026-06-29 Listings Reported a reverse stock split. SEC Form 8-K (Items 3.03,5.03,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1041024/000162828026045866/rmti-20260624.htm) 3. 2026-06-15 Listings Reported a shareholder vote on a reverse stock split or more authorized shares. SEC Form 8-K (Items 5.07). [Source](https://www.sec.gov/Archives/edgar/data/1041024/000162828026043210/rmti-20260612.htm) 4. 2026-05-08 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01). [Source](https://www.sec.gov/Archives/edgar/data/1041024/000162828026032987/rmti-20260508.htm) 5. 2026-04-30 Listings Asked shareholders to approve a reverse stock split. SEC Form DEF 14A. [Source](https://www.sec.gov/Archives/edgar/data/1041024/000162828026028571/rmti-20260428.htm) 6. 2026-04-20 Listings Asked shareholders to approve a reverse stock split. SEC Form PRE 14A. [Source](https://www.sec.gov/Archives/edgar/data/1041024/000162828026025997/rmti-20260420.htm) 7. 2024-11-13 Financings Set up an at-the-market program to sell shares over time. SEC Form 424B5. [Source](https://www.sec.gov/Archives/edgar/data/1041024/000110465924117331/tm2428115-1_424b5.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:RMTI on TradingView](https://www.tradingview.com/symbols/NASDAQ-RMTI/). ## SEC filings and registration - **SEC name**: Rockwell Medical, Inc. - **CIK**: 1041024 - **Industry (SIC)**: Pharmaceutical Preparations (2834) - **US tickers**: RMTI (Nasdaq) - **State or country of incorporation**: DE - **Fiscal year ends**: December 31 - **Filer category**: Non-accelerated filer
Smaller reporting company - **Business address**: 30142 WIXOM ROAD, WIXOM, MI, 48393 - **Phone**: 8004493353 - **Shares outstanding**: 4,030,465 as of 2026-08-10 (10-Q filed 2026-08-13) - **Former names**: ROCKWELL MEDICAL TECHNOLOGIES INC ### Recent filings (8-K and 6-K are the company's own announcements) - [8-K](https://www.sec.gov/Archives/edgar/data/1041024/000162828026056470/rmti-20260813.htm) filed 2026-08-13 - [10-Q](https://www.sec.gov/Archives/edgar/data/1041024/000162828026056461/rmti-20260630.htm) filed 2026-08-13 - [8-K](https://www.sec.gov/Archives/edgar/data/1041024/000162828026056454/rmti-20260813.htm) filed 2026-08-13 - [8-K](https://www.sec.gov/Archives/edgar/data/1041024/000162828026048752/rmti-20260720.htm) filed 2026-07-20 - [8-K](https://www.sec.gov/Archives/edgar/data/1041024/000162828026045866/rmti-20260624.htm) filed 2026-06-29 - [8-K](https://www.sec.gov/Archives/edgar/data/1041024/000162828026043210/rmti-20260612.htm) filed 2026-06-15 - [8-K](https://www.sec.gov/Archives/edgar/data/1041024/000162828026032987/rmti-20260508.htm) filed 2026-05-08 - [8-K](https://www.sec.gov/Archives/edgar/data/1041024/000162828026031680/rmti-20260507.htm) filed 2026-05-07 Source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001041024), retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices. ## Listing details Rockwell Medical, Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker RMTI, recorded under United States. The directory classifies it as Biopharma / pharmaceuticals. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Rockwell Medical, Inc. - **Ticker**: RMTI - **Listing**: NASDAQ - **Country or territory**: United States - **Business scope**: Biopharma / pharmaceuticals - **ISIN**: US7743744093 - **Last quote in directory**: 2026-10-21 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/NASDAQ-RMTI/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/rockwell-medical/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Rockwell Medical (RMTI) news: reverse split", 2026-10-31, https://aibio.space/companies/rockwell-medical/